FIFTH AMENDMENT TO LOAN AND SECURITY AGREEMENTLoan and Security Agreement • May 15th, 2023 • Alimera Sciences Inc • Pharmaceutical preparations • New York
THIS FIFTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (this “Amendment”), dated as of March 24, 2023 (the “Fifth Amendment Effective Date”), by and among SLR Investment Corp., a Maryland corporation (formerly known as Solar Capital LTD.) (“SLR”), as collateral agent (in such capacity, together with its successors and assigns in such capacity, “Collateral Agent”), the lenders party hereto including SLR in its capacity as a Lender (each a “Lender” and collectively, the “Lenders”), and Alimera Sciences, Inc., a Delaware corporation (“Borrower”).
Fifth Amendment Exit Fee AgreementLoan and Security Agreement • May 15th, 2023 • Alimera Sciences Inc • Pharmaceutical preparations • New York
Reference is made to the Loan and Security Agreement, dated as of December 31, 2019 (as amended, amended and restated, supplemented or otherwise modified from time to time, the “Loan Agreement”) by and among SLR Investment Corp., a Maryland corporation (formerly known as Solar Capital Ltd.) (“Solar”), as collateral agent (in such capacity, “Agent”), the lenders party thereto from time to time including Solar in its capacity as a lender (each a “Lender” and collectively, the “Lenders”), and Alimera Sciences, Inc., a Delaware corporation (“Borrower”). As a condition precedent to the Lenders’ entry into the Fifth Amendment, the Lenders require that Borrower agree to pay to the Lenders a fee upon the occurrence of certain events, as described in this Fifth Amendment Exit Fee Agreement (as amended, amended and restated, supplemented or otherwise modified from time to time, this “Agreement”), dated as of March 24, 2023 (the “Fifth Amendment Effective Date”), by and among Solar as Agent, the
